Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Liposomal nanoformulations of cannabidiol with celecoxib or 2,5-dimethylcelecoxib as a novel treatment option for glioblastoma multiforme

2021/43/O/NZ5/02346

Keywords:

Cannabidiol Celecoxib 2,5- Dimethylcelecoxib NF-kB Nrf2 Wnt glioblastoma multiforme

Descriptors:

  • NZ5_3: Pathogenesis of human diseases
  • NZ5_7: Human disease treatment

Panel:

NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution :

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

woj. wielkopolskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr hab. Violetta Krajka-Kuźniak 

Number of co-investigators in the project: 2

Call: PRELUDIUM BIS 3 - announced on 2021-09-15

Amount awarded: 602 490 PLN

Project start date (Y-m-d): 2022-06-24

Project end date (Y-m-d): 2025-09-30

Project duration:: 36 months (the same as in the proposal)

Project status: Pending project

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.